Key result
Halothane and isoflurane were associated with similar incidences of respiratory complications in COPD patients, though tachycardia was significantly more frequent with isoflurane.
Authors
Loading...
Neither agent shows respiratory advantage in COPD; tachycardia association with isoflurane warrants confirmation in randomized studies.
RCT (n=148)
Randomly assigned
Gold et al. (1983) conducted an RCT in Chronic obstructive pulmonary disease (COPD) (n=148). Halothane vs. Isoflurane was evaluated on Intra- and postoperative respiratory complications. Halothane and isoflurane were associated with similar incidences of respiratory complications in COPD patients, though tachycardia was significantly more frequent with isoflurane.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: